Clinical Trial Update: Effect of LEQEMBI on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer's Disease

View source ↗

Summary

A clinical trial is evaluating LEQEMBI (lecanemab) for its effects on cerebral and retinal amyloid in individuals with Mild Cognitive Impairment due to Alzheime…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• LEQEMBI (lecanemab)

Snippet

Sponsor: NeuroVision Imaging | Conditions: Mild Cognitive Impairment, Alzheimer Disease | Status: RECRUITING